NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment

… NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment … Helen M. Moore, PhD …

First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology

Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research

… Druggable Drivers of NSCLC—and New Avenue for Continued Research … Beth Fand Incollingo …

Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

… Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research …

Making Mesothelioma Patient Research Happen: The United Kingdom Experience

… Making Mesothelioma Patient Research Happen: The United Kingdom Experience …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

A Shift in Focus: Real-World Data Reframe the Value of N1 Nodal Assessments in Resection

… lung cancer resection. Historically, much of the data and research have largely focused on examining N2 lymph nodes … extensive sampling,” Dr. Seder said. He noted that future research will aim to analyze the data by tumor …

From Sequencing to Treatment: The Role of Comprehensive Genome Profiling, Molecular Tumor Boards in Advanced-Stage NSCLC

… Gap Precision oncology in NSCLC has moved decisively from research to clinical practice. The FPG500 program demonstrated … A. Gemelli IRCCS in Rome, Italy. His main clinical and research interests are centered on precision oncology and … information to support translational and clinical research projects. Emilio Bria Dr. Bria is a Medical …

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

… in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards … in Victoria, Australia. His clinical and translational research has identified new treatments, changed the standards …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC